4.06
Schlusskurs vom Vortag:
$4.05
Offen:
$4.03
24-Stunden-Volumen:
593.94K
Relative Volume:
1.03
Marktkapitalisierung:
$288.15M
Einnahmen:
$299.48M
Nettoeinkommen (Verlust:
$-86.45M
KGV:
-2.7067
EPS:
-1.5
Netto-Cashflow:
$-17.32M
1W Leistung:
+7.69%
1M Leistung:
+7.12%
6M Leistung:
-44.65%
1J Leistung:
-33.44%
Health Catalyst Inc Stock (HCAT) Company Profile
Firmenname
Health Catalyst Inc
Sektor
Branche
Telefon
801-708-6800
Adresse
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Vergleichen Sie HCAT mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
HCAT
Health Catalyst Inc
|
4.06 | 288.15M | 299.48M | -86.45M | -17.32M | -1.50 |
![]()
VEEV
Veeva Systems Inc
|
282.61 | 46.43B | 2.86B | 780.66M | 1.20B | 4.72 |
![]()
TEM
Tempus Ai Inc
|
59.18 | 12.01B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
DOCS
Doximity Inc
|
59.31 | 10.79B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
HQY
Healthequity Inc
|
101.28 | 9.27B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
38.67 | 7.03B | 906.14M | -52.62M | 89.62M | -0.3621 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-04-09 | Herabstufung | Evercore ISI | Outperform → In-line |
2025-01-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
2024-04-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
2024-01-03 | Eingeleitet | Barclays | Overweight |
2024-01-03 | Hochstufung | Evercore ISI | In-line → Outperform |
2023-12-13 | Hochstufung | JP Morgan | Neutral → Overweight |
2023-11-13 | Hochstufung | Piper Sandler | Neutral → Overweight |
2023-08-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
2023-05-10 | Herabstufung | Guggenheim | Buy → Neutral |
2023-05-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
2023-04-20 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
2023-04-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
2022-10-31 | Eingeleitet | Wells Fargo | Equal Weight |
2022-10-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
2022-09-13 | Herabstufung | Piper Sandler | Overweight → Neutral |
2022-08-05 | Herabstufung | JP Morgan | Overweight → Neutral |
2022-08-05 | Herabstufung | Stifel | Buy → Hold |
2022-04-14 | Eingeleitet | Guggenheim | Buy |
2022-03-17 | Hochstufung | Jefferies | Hold → Buy |
2022-02-11 | Eingeleitet | Goldman | Buy |
2021-12-02 | Eingeleitet | Jefferies | Hold |
2021-10-14 | Eingeleitet | BTIG Research | Buy |
2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
2020-12-08 | Eingeleitet | Berenberg | Buy |
2020-07-14 | Eingeleitet | Citigroup | Buy |
2020-06-18 | Eingeleitet | Stifel | Buy |
2020-06-15 | Fortgesetzt | Evercore ISI | Outperform |
2020-05-15 | Eingeleitet | Guggenheim | Buy |
2020-04-21 | Eingeleitet | RBC Capital Mkts | Outperform |
2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
2020-04-02 | Eingeleitet | Canaccord Genuity | Buy |
2019-12-20 | Eingeleitet | Raymond James | Strong Buy |
2019-10-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
2019-08-19 | Eingeleitet | Evercore ISI | Outperform |
2019-08-19 | Eingeleitet | Goldman | Buy |
2019-08-19 | Eingeleitet | JP Morgan | Overweight |
2019-08-19 | Eingeleitet | Piper Jaffray | Overweight |
2019-08-19 | Eingeleitet | SVB Leerink | Outperform |
2019-08-19 | Eingeleitet | SunTrust | Buy |
2019-08-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Health Catalyst Inc Aktie (HCAT) Neueste Nachrichten
Health Catalyst stock downgraded by BTIG on healthcare coverage concerns - Investing.com South Africa
Health Catalyst (HCAT) Faces Downgrade Amid Financial Pressures - GuruFocus
Data Analytics Stocks Q1 Teardown: Health Catalyst (NASDAQ:HCAT) Vs The Rest - Yahoo Finance
BTIG Downgrades Health Catalyst to Neutral From Buy - MarketScreener
Health Catalyst’s SWOT analysis: data analytics firm navigates healthcare shifts - Investing.com Nigeria
(HCAT) Technical Data - news.stocktradersdaily.com
HCAT Q1 Earnings Call: Ignite Platform Drives Client Growth Amid Funding Uncertainty - Yahoo Finance
Health Catalyst: Ignite Platform Is A Growth Catalyst (NASDAQ:HCAT) - Seeking Alpha
Stifel maintains Health Catalyst stock Hold rating, $5.50 target By Investing.com - Investing.com South Africa
Stifel maintains Health Catalyst stock Hold rating, $5.50 target - Investing.com Australia
Health Catalyst, Steven Madden, Astronics, Wayfair, and Robinhood Shares Are Soaring, What You Need To Know - Yahoo Finance
Deutsche Bank AG Acquires 19,659 Shares of Health Catalyst, Inc. (NASDAQ:HCAT) - Defense World
Health catalyst sees 10% technology revenue growth in Q1 2025 amid Ignite platform adoption - MSN
Health Catalyst stock hits 52-week low at $3.54 amid market challenges - Investing.com Australia
Health Catalyst stock hits 52-week low at $3.54 amid market challenges By Investing.com - Investing.com South Africa
BNP Paribas Financial Markets Makes New Investment in Health Catalyst, Inc. (NASDAQ:HCAT) - Defense World
Health Catalyst’s SWOT analysis: ignite platform fuels stock growth hopes By Investing.com - Investing.com Nigeria
Northern Trust Corp Acquires 41,298 Shares of Health Catalyst, Inc. (NASDAQ:HCAT) - Defense World
Health Catalyst’s SWOT analysis: ignite platform fuels stock growth hopes - Investing.com Australia
Health Catalyst to Participate in Upcoming Investor Conferences - The Manila Times
Learn to Evaluate (HCAT) using the Charts - news.stocktradersdaily.com
1 Mooning Stock Worth Your Attention and 2 to Avoid - Yahoo Finance
Health Catalyst (NASDAQ:HCAT) Price Target Raised to $5.50 - Defense World
Dimensional Fund Advisors LP Increases Stake in Health Catalyst, Inc. (NASDAQ:HCAT) - Defense World
Health Catalyst, Inc. (NASDAQ:HCAT) Q1 2025 Earnings Call Transcript - Insider Monkey
Health Catalyst, Inc. (NASDAQ:HCAT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates - simplywall.st
Health Catalyst First Quarter 2025 Earnings: EPS Misses Expectations - Yahoo Finance
Health Catalyst (HCAT): Analyst Maintains Buy Rating, Lowers Price Target | HCAT Stock News - GuruFocus
Envestnet Asset Management Inc. Purchases 16,208 Shares of Health Catalyst, Inc. (NASDAQ:HCAT) - Defense World
Health Catalyst (HCAT) Target Price Raised by Stifel Analyst | H - GuruFocus
Health Catalyst (HCAT) Target Price Raised by Stifel Analyst | HCAT Stock News - GuruFocus
Breaking Down Health Catalyst: 9 Analysts Share Their Views - Benzinga
Evercore ISI lifts Health Catalyst stock to $5 target By Investing.com - Investing.com South Africa
Canaccord cuts Health Catalyst price target to $9, maintains buy By Investing.com - Investing.com Australia
Canaccord Adjusts Price Target for Health Catalyst (HCAT), Remai - GuruFocus
Canaccord cuts Health Catalyst price target to $9, maintains buy - Investing.com
Canaccord Adjusts Price Target for Health Catalyst (HCAT), Remains Optimistic | HCAT Stock News - GuruFocus
Evercore ISI lifts Health Catalyst stock to $5 target - Investing.com Australia
Detailed Analysis of Population Based Health Services Market | - openPR.com
Health Catalyst: Q1 Earnings Snapshot - The Washington Post
Finanzdaten der Health Catalyst Inc-Aktie (HCAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):